US OptionsDetailed Quotes
ALUR241220P2500
- 1.83
- 0.000.00%
15min DelayClose Dec 20 15:59 ET
0.00High0.00Low
0.00Open1.83Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-93.08%PremiumDec 20, 2024Expiry Date2.15Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.19Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Allurion Technologies Stock Discussion
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
Monday, 2nd December at 8:00 am
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock Exchange (the "NYSE") stating that the NYSE has accepted the Company's previously submitted plan to regain compliance with the NYSE's continued listing standard s...
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
3. NEVER open position without momentum.
4. If you are expecting all stocks to be a runner,then you are set for failure, losses, and bagholding. Not all good news run and not all bad news crash the pri...
$Gorilla Technology (GRRR.US)$ we load at 5 and we hit 6.6
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...
Benzinga· 2 mins ago
No comment yet